Detalhe da pesquisa
1.
An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.
Cancer Immunol Immunother
; 68(8): 1379-1389, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338557
2.
Tissue microRNA expression profiling in hepatic and pulmonary metastatic melanoma.
Melanoma Res
; 30(5): 455-464, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32804708
3.
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 25(16): 4955-4965, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31142501
4.
Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor.
Oncoimmunology
; 6(5): e1312045, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28638738
5.
Structural characterization of NRAS isoform 5.
Protein Sci
; 25(5): 1069-74, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26947772